Human amniotic fluid-derived mesenchymal cells from fetuses with a neural tube defect do not deposit collagen type i protein after TGF-β1 stimulation in vitro

Stem Cells and Development

Volumn 23, Issue 5, 2014, Pages 555-562

  Hosper, Nynke A ^a   Bank, Ruud A ^a   Van Den Berg, Paul P ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMNIOTIC FLUID; COLLAGEN TYPE I; FEMALE; FETUS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; NEURAL TUBE; PREGNANCY; RNA, MESSENGER; SPINAL DYSRAPHISM; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84894365855     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2013.0334     Document Type: Article

References (48)

1. Adzick NS. (2012). Fetal surgery for myelomeningocele: Trials and tribulations. J Pediatr Surg 47:273-281.
2. Fichter MA, U Dornseifer, J Henke, KT Schneider, L Kovacs, E Biemer, J Bruner, NS Adzick, MR Harrison and NA Papadopulos. (2008). Fetal spina bifida repair-current trends and prospects of intrauterine neurosurgery. Fetal Diagn Ther 23:271-286.
3. Danzer E, MP Johnson and NS Adzick. (2012). Fetal surgery for myelomeningocele: Progress and perspectives. Dev Med Child Neurol 54:8-14.
4. Adzick NS, EAThom, CY Spong, JW Brock, III, PK Burrows, MP Johnson, LJ Howell, JA Farrell, ME Dabrowiak, et al. (2011). A randomized trial of prenatal versus postnatal repair of myelomeningocele. N Engl J Med 364:993-1004.
5. Hosper NA, AJ Eggink, LA Roelofs, RM Wijnen, MJ van Luyn, RA Bank, MC Harmsen, PJ Geutjes, WF Daamen, et al. (2010). Intra-uterine tissue engineering of full-Thickness skin defects in a fetal sheep model. Biomaterials 31:3910-3919.
6. Watanabe M, J Jo, A Radu, M Kaneko, Y Tabata and AW Flake. (2010). A tissue engineering approach for prenatal closure of myelomeningocele with gelatin sponges incorporating basic fibroblast growth factor. Tissue Eng Part A 16:1645-1655.
7. Watanabe M, H Li, J Roybal, M Santore, A Radu, J Jo, M Kaneko, Y Tabata and A Flake. (2011). A tissue engineering approach for prenatal closure of myelomeningocele: Comparison of gelatin sponge and microsphere scaffolds and bioactive protein coatings. Tissue Eng Part A 17:1099-1110.
8. Saadai P, YS Nout, J Encinas, A Wang, TL Downing, MS Beattie, JC Bresnahan, S Li and DL Farmer. (2011). Prenatal repair of myelomeningocele with aligned nanofibrous scaffolds-A pilot study in sheep. J Pediatr Surg 46:2279-2283.
9. Eggink AJ, LA Roelofs, WF Feitz, RM Wijnen, RA Mullaart, JA Grotenhuis, TH van Kuppevelt, MM Lammens, AJ Crevels, A Hanssen and PP Van Den Berg. (2005). In utero repair of an experimental neural tube defect in a chronic sheep model using biomatrices. Fetal Diagn Ther 20:335-340.
10. Eggink AJ, LA Roelofs, MM Lammens, WF Feitz, RM Wijnen, RA Mullaart, HT van Moerkerk, TH van Kuppevelt, AJ Crevels, et al. (2006). Histological evaluation of acute covering of an experimental neural tube defect with biomatrices in fetal sheep. Fetal Diagn Ther 21:210-216.
11. Eggink AJ, LA Roelofs,WF Feitz, RMWijnen, MM Lammens, RA Mullaart, HT van Moerkerk, TH van Kuppevelt, AJ Crevels, et al. (2008). Delayed intrauterine repair of an experimental spina bifida with a collagen biomatrix. Pediatr Neurosurg 44:29-35.
12. Kaviani A, TE Perry, A Dzakovic, RW Jennings, MM Ziegler and DO Fauza. (2001). The amniotic fluid as a source of cells for fetal tissue engineering. J Pediatr Surg 36:1662-1665.
13. Kaviani A, K Guleserian, TE Perry, RW Jennings, MM Ziegler and DO Fauza. (2003). Fetal tissue engineering from amniotic fluid. J Am Coll Surg 196:592-597.
14. Fuchs JR, A Kaviani, JT Oh, D LaVan, T Udagawa, RW Jennings, JM Wilson and DO Fauza. (2004). Diaphragmatic reconstruction with autologous tendon engineered from mesenchymal amniocytes. J Pediatr Surg 39:834-838.
15. Kunisaki SM, M Armant, GS Kao, K Stevenson, H Kim and DO Fauza. (2007). Tissue engineering from human mesenchymal amniocytes: A prelude to clinical trials. J Pediatr Surg 42:974-979.
16. Steigman SA, M Armant, L Bayer-Zwirello, GS Kao, L Silberstein, J Ritz and DO Fauza. (2008). Preclinical regulatory validation of a 3-stage amniotic mesenchymal stem cell manufacturing protocol. J Pediatr Surg 43:1164-1169.
17. Fauza D. (2004). Amniotic fluid and placental stem cells. Best Pract Res Clin Obstet Gynaecol 18:877-891.
18. Kunisaki SM, DA Freedman and DO Fauza. (2006). Fetal tracheal reconstruction with cartilaginous grafts engineered from mesenchymal amniocytes. J Pediatr Surg 41:675-682.
19. Kunisaki SM, JR Fuchs, SA Steigman and DO Fauza. (2007). A comparative analysis of cartilage engineered from different perinatal mesenchymal progenitor cells. Tissue Eng 13:2633-2644.
20. Klemmt PA, V Vafaizadeh and B Groner. (2011). The potential of amniotic fluid stem cells for cellular therapy and tissue engineering. Expert Opin Biol Ther 11:1297-1314.
21. Antonucci I, L Stuppia, Y Kaneko, S Yu, N Tajiri, EC Bae, SH Chheda, NL Weinbren and CV Borlongan. (2011). Amniotic fluid as a rich source of mesenchymal stromal cells for transplantation therapy. Cell Transplant 20:789-795.
22. Weber B, SM Zeisberger and SP Hoerstrup. (2011). Prenatally harvested cells for cardiovascular tissue engineering: Fabrication of autologous implants prior to birth. Placenta 32 Suppl 4:S316-S319.
23. Saxena AK. (2010). Congenital anomalies of soft tissues: Birth defects depending on tissue engineering solutions and present advances in regenerative medicine. Tissue Eng Part B Rev 16:455-466.
24. In 't Anker PS, SA Scherjon, C Kleijburg-van der Keur, WA Noort, FH Claas, R Willemze, WE Fibbe and HH Kanhai. (2003). Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood 102:1548-1549.
25. De Coppi P, A Callegari, A Chiavegato, L Gasparotto, M Piccoli, J Taiani, M Pozzobon, L Boldrin, M Okabe, et al. (2007). Amniotic fluid and bone marrow derived mesenchymal stem cells can be converted to smooth muscle cells in the cryo-injured rat bladder and prevent compensatory hypertrophy of surviving smooth muscle cells. J Urol 177: 369-376.
26. Roubelakis MG, KI Pappa, V Bitsika, D Zagoura, A Vlahou, HA Papadaki, A Antsaklis and NP Anagnou. (2007). Molecular and proteomic characterization of human mesenchymal stem cells derived from amniotic fluid: Comparison to bone marrow mesenchymal stem cells. Stem Cells Dev 16:931-952.
27. Sessarego N, A Parodi, M Podesta, F Benvenuto, M Mogni, V Raviolo, M Lituania, A Kunkl, G Ferlazzo, et al. (2008). Multipotent mesenchymal stromal cells from amniotic fluid: Solid perspectives for clinical application. Haematologica 93:339-346.
28. Woodbury D, BC Kramer, K Reynolds, AJ Marcus, TM Coyne and IB Black. (2006). Long-Term cryopreserved amniocytes retain proliferative capacity and differentiate to ectodermal and mesodermal derivatives in vitro. Mol Reprod Dev 73:1463-1472.
29. Delo DM, P De Coppi, G Bartsch, Jr. and A Atala. (2006). Amniotic fluid and placental stem cells. Methods Enzymol 419:426-438.
30. Cananzi M, A Atala and P De Coppi. (2009). Stem cells derived from amniotic fluid: New potentials in regenerative medicine. Reprod Biomed Online 18 Suppl 1:17-27.
31. De Coppi P, G Bartsch, Jr., MM Siddiqui, T Xu, CC Santos, L Perin, G Mostoslavsky, AC Serre, EY Snyder, et al. (2007). Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 25:100-106.
32. Hartmann-Fritsch F, N Hosper, J Luginbuhl, T Biedermann, E Reichmann and M Meuli. (2013). Human amniotic fluid derived cells can competently substitute dermal fibroblasts in a tissue-engineered dermo-epidermal skin analog. Pediatr Surg Int 29:61-69.
33. Pittenger MF, AM Mackay, SC Beck, RK Jaiswal, R Douglas, JD Mosca, MA Moorman, DW Simonetti, S Craig and DR Marshak. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147.
34. Covas DT, RA Panepucci, AM Fontes, WA Silva, Jr., MD Orellana, MC Freitas, L Neder, AR Santos, LC Peres, MC Jamur and MA Zago. (2008). Multipotent mesenchymal stromal cells obtained fromdiverse human tissues share functional properties and gene-expression profile with CD146 + perivascular cells and fibroblasts. Exp Hematol 36:642-654.
35. Blasi A, C Martino, L Balducci, M Saldarelli, A Soleti, SE Navone, L Canzi, S Cristini, G Invernici, EA Parati and G Alessandri. (2011). Dermal fibroblasts display similar phenotypic and differentiation capacity to fat-derived mesenchymal stem cells, but differ in anti-inflammatory and angiogenic potential. Vasc Cell 3:5.
36. Cappellesso-Fleury S, B Puissant-Lubrano, PA Apoil, M Titeux, P Winterton, L Casteilla, P Bourin and A Blancher. (2010). Human fibroblasts share immunosuppressive properties with bone marrow mesenchymal stem cells. J Clin Immunol 30:607-619.
37. Runger TM, MJ Quintanilla-Dieck and J Bhawan. (2007). Role of cathepsin K in the turnover of the dermal extracellular matrix during scar formation. J Invest Dermatol 127:293-297.
38. Quintanilla-Dieck MJ, K Codriansky, M Keady, J Bhawan and TM Runger. (2009). Expression and regulation of cathepsin K in skin fibroblasts. Exp Dermatol 18:596-602.
39. Heffez DS, J Aryanpur, GM Hutchins and JM Freeman. (1990). The paralysis associated with myelomeningocele: Clinical and experimental data implicating a preventable spinal cord injury. Neurosurgery 26:987-992.
40. Meuli M, C Meuli-Simmen, GM Hutchins, CD Yingling, KM Hoffman, MR Harrison and NS Adzick. (1995). In utero surgery rescues neurological function at birth in sheep with spina bifida. Nat Med 1:342-347.
41. Walsh DS, NS Adzick, LN Sutton and MP Johnson. (2001). The Rationale for in utero repair of myelomeningocele. Fetal Diagn Ther 16:312-322.
42. Shields LE, B Lindton, RG Andrews and M Westgren. (2002). Fetal hematopoietic stem cell transplantation: A challenge for the twenty-first century. J Hematother Stem Cell Res 11:617-631.
43. MRC Vitamin Study Research Group. (1991). Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study. Lancet 338:131-137.
44. Lammer EJ, LE Sever and GP Oakley, Jr. (1987). Teratogen update: Valproic acid. Teratology 35:465-473.
45. Matalon S, S Schechtman, G Goldzweig and A Ornoy. (2002). The teratogenic effect of carbamazepine: A metaanalysis of 1255 exposures. Reprod Toxicol 16:9-17.
46. Klein JD, CG Turner, SA Steigman, A Ahmed, D Zurakowski, E Eriksson and DO Fauza. (2011). Amniotic mesenchymal stem cells enhance normal fetal wound healing. Stem Cells Dev 20:969-976.
47. Pennington EC, FL Gray, A Ahmed, D Zurakowski and DO Fauza. (2013). Targeted quantitative amniotic cell profiling: A potential diagnostic tool in the prenatal management of neural tube defects. J Pediatr Surg 48:1205-1210.
48. Turner CG, JD Klein, J Wang, D Thakor, D Benedict, A Ahmed, YD Teng and DO Fauza. (2013). The amniotic fluid as a source of neural stem cells in the setting of experimental neural tube defects. Stem Cells Dev 22:548-553.